Geode Capital Management, LLC Cure Vac N.V. Transaction History

Geode Capital Management, LLC

$1.21 Trillion
Q3 2024

A detailed history of Geode Capital Management, LLC transactions in Cure Vac N.V. stock. As of the latest transaction made, Geode Capital Management, LLC holds 219,259 shares of CVAC stock, worth $545,954. This represents 0.0% of its overall portfolio holdings.

Number of Shares

219,259

Previous 261,230 16.07%

Holding current value

$545,954

Previous $888,000 27.48%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$2.74 - $3.79 $115,000 - $159,070	-41,971 Reduced 16.07%	219,259 $644,000
Q2 2024 Aug 09, 2024	BUY	$2.31 - $4.99 $120,849 - $261,056	52,316 Added 25.04%	261,230 $888,000
Q1 2024 May 13, 2024	BUY	$2.94 - $4.34 $20,327 - $30,006	6,914 Added 3.42%	208,914 $633,000
Q4 2023 Feb 13, 2024	BUY	$3.96 - $6.41 $10,573 - $17,114	2,670 Added 1.34%	202,000 $850,000
Q3 2023 Nov 13, 2023	BUY	$6.5 - $10.77 $125,827 - $208,485	19,358 Added 10.76%	199,330 $1.36 Million
Q2 2023 Aug 11, 2023	BUY	$6.69 - $12.25 $85,431 - $156,432	12,770 Added 7.64%	179,972 $1.88 Million
Q1 2023 May 15, 2023	BUY	$6.38 - $12.5 $7,579 - $14,850	1,188 Added 0.72%	167,202 $1.17 Million
Q4 2022 Feb 13, 2023	BUY	$5.75 - $8.5 $81,604 - $120,632	14,192 Added 9.35%	166,014 $1 Million
Q3 2022 Nov 14, 2022	BUY	$7.48 - $15.24 $16,358 - $33,329	2,187 Added 1.46%	151,822 $1.2 Million
Q2 2022 Aug 12, 2022	SELL	$13.18 - $19.41 $2.2 Million - $3.24 Million	-167,141 Reduced 52.76%	149,635 $2.04 Million
Q1 2022 May 13, 2022	BUY	$14.73 - $35.25 $222,614 - $532,733	15,113 Added 5.01%	316,776 $6.21 Million
Q4 2021 Feb 11, 2022	BUY	$33.72 - $48.22 $316,158 - $452,110	9,376 Added 3.21%	301,663 $10.4 Million
Q3 2021 Nov 12, 2021	BUY	$49.26 - $74.5 $417,232 - $631,015	8,470 Added 2.98%	292,287 $16 Million
Q2 2021 Aug 13, 2021	BUY	$56.91 - $127.53 $8.21 Million - $18.4 Million	144,331 Added 103.47%	283,817 $20.9 Million
Q1 2021 May 12, 2021	BUY	$79.79 - $126.29 $762,393 - $1.21 Million	9,555 Added 7.35%	139,486 $12.8 Million
Q4 2020 Feb 12, 2021	SELL	$46.76 - $136.27 $44,281 - $129,047	-947 Reduced 0.72%	129,931 $10.5 Million
Q3 2020 Nov 13, 2020	BUY	$43.8 - $77.2 $5.73 Million - $10.1 Million	130,878 New	130,878 $6.09 Million

Others Institutions Holding CVAC

# of Institutions

Shares Held

12.3M

Call Options Held

164K

Put Options Held

117K

View Full List

About CureVac N.V.

Ticker CVAC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,467,008
Market Cap $467M
Description
CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202, a prophylactic mRNA-based vaccine, which ...

More about CVAC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account

Geode Capital Management, LLC Cure Vac N.V. Transaction History